M. Rubio

J. Muntané, C. Díaz-Iglesias, R. Ciria, 2007, Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico.

Radical surgery‐peritonectomy and intraoperative intraperitoneal chemotherapy for the treatment of peritoneal carcinomatosis in recurrent or primary ovarian cancer

J. Muntané, R. Ciria, J. Briceño, 2006, Journal of surgical oncology.

Peritonectomy procedures and HIPEC in the treatment of peritoneal carcinomatosis from ovarian cancer: Long-term outcomes and perspectives from a high-volume center.

F. J. Briceño, F. J. Medina-Fernández, F. C. Muñoz-Casares, 2016, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

GEICO (Spanish Group for Investigation on Ovarian Cancer) treatment guidelines in ovarian cancer 2012

J. López-Guerrero, A. de Juan, A. Cervantes, 2013, Clinical and Translational Oncology.

Randomized phase II trial of farletuzumab plus chemotherapy versus placebo plus chemotherapy in low CA-125 platinum-sensitive ovarian cancer.

B. Monk, R. Wenham, H. Gabra, 2023, Gynecologic oncology.

Antitumor activity of lurbinectedin in second-line small cell lung cancer patients who are candidates for re-challenge with the first-line treatment.

S. Peters, A. Santoro, K. Zaman, 2020, Lung cancer.

Efficacy and safety of trabectedin in metastatic uterine leiomyosarcoma: A retrospective multicenter study of the Spanish ovarian cancer research group (GEICO)

J. Calzas, L. Gaba, P. Barretina, 2020, Gynecologic oncology reports.

Prospective Real-World Gynaecological Cancer Clinical Registry with Associated Biospecimens: A Collaborative Model to Promote Translational Research between GEICO and the Spanish Biobank Network

J. López-Guerrero, M. Mendiola, A. de Juan, 2022, Cancers.

Open-label phase II clinical trial of ketoconazole as CYP17 inhibitor in metastatic or advanced non-resectable granulosa cell ovarian tumors: the GREKO (GRanulosa Et KetOconazole) trial, GETHI 2011-03.

J. Cueva, J. López-Guerrero, J. García-Donas, 2023, Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico.

Management of advanced ovarian cancer in Spain: an expert Delphi consensus

A. de Juan, A. Poveda, A. Oaknin, 2021, Journal of Ovarian Research.

The role of hyperthermic intraoperative intraperitoneal chemotherapy (HIPEC) in the treatment of peritoneal carcinomatosis in recurrent ovarian cancer

J. Muntané, S. Rufián, F. C. Muñoz-Casares, 2009, Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico.

Neoadjuvant intraperitoneal chemotherapy with paclitaxel for the radical surgical treatment of peritoneal carcinomatosis in ovarian cancer: a prospective pilot study

J. Muntané, C. Díaz-Iglesias, E. Aranda, 2011, Cancer Chemotherapy and Pharmacology.

Retrospective multicenter study of elderly patients with platinum-sensitive relapsed ovarian cancer treated with trabectedin and pegylated liposomal doxorubicin (pld) in a real-world setting: a geico study

A. Manzano, M. Rubio, L. D. de Sande, 2024, BMC cancer.

J. Cueva, J. López-Guerrero, J. García-Donas, 2023, Clinical and Translational Oncology.